Avior Wealth Management LLC Lowers Holdings in Kenvue Inc. (NYSE:KVUE)

Avior Wealth Management LLC reduced its stake in shares of Kenvue Inc. (NYSE:KVUE) by 9.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,279 shares of the company’s stock after selling 1,602 shares during the period. Avior Wealth Management LLC’s holdings in Kenvue were worth $350,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. purchased a new stake in shares of Kenvue during the 3rd quarter worth $2,944,816,000. FMR LLC boosted its position in shares of Kenvue by 572.1% in the 3rd quarter. FMR LLC now owns 89,182,980 shares of the company’s stock worth $1,790,794,000 after buying an additional 75,913,107 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Kenvue by 576.1% in the 3rd quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock worth $1,439,472,000 after buying an additional 61,084,123 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Kenvue by 227.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company’s stock worth $1,226,711,000 after buying an additional 42,449,470 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Kenvue by 4,057.4% in the 3rd quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock worth $625,745,000 after buying an additional 30,413,040 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently commented on KVUE. Sanford C. Bernstein began coverage on shares of Kenvue in a research report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. William Blair began coverage on shares of Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Royal Bank of Canada decreased their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, February 9th. The Goldman Sachs Group initiated coverage on shares of Kenvue in a research report on Friday, March 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Finally, JPMorgan Chase & Co. cut their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research note on Friday, February 9th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $24.85.

Kenvue Stock Performance

NYSE KVUE opened at $19.58 on Friday. Kenvue Inc. has a 12 month low of $17.82 and a 12 month high of $27.80. The company has a 50-day moving average of $19.84 and a 200-day moving average of $20.16. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The business had revenue of $3.67 billion during the quarter, compared to analysts’ expectations of $3.78 billion. The company’s revenue was down 2.7% compared to the same quarter last year. On average, analysts anticipate that Kenvue Inc. will post 1.15 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Wednesday, February 14th were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.09%. The ex-dividend date of this dividend was Tuesday, February 13th.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.